Clopidogrel Response Evaluation and AnTi-Platelet InterVEntion in High Thrombotic Risk PCI Patients
Status:
Completed
Trial end date:
2016-09-01
Target enrollment:
Participant gender:
Summary
To identify the high-risk patients who might have in-stent thrombosis after PCI with
thromboelastography and to head-to-head compare two intensified antiplatelet therapeutic
strategies of double-dosage Clopidogrel and triple antiplatelet therapy with Cilostazol with
the standard antiplatelet therapy.
Phase:
N/A
Details
Lead Sponsor:
Chinese Academy of Medical Sciences, Fuwai Hospital
Collaborators:
Beijing Municipal Health Bureau Haemonetics Corporation Zhejiang Otsuka Pharmaceutical Co., Ltd.